At JPM, Bristol’s new CEO tries to soothe investors’ nerves

In trying to sell Bristol to investors on Monday at the JPM conference, he pointed to the company's 150-year history.

January 8, 2024 Check out STAT+

Sponsored By

Business Wire via AP STAT+ | At JPM, Bristol's new CEO appeals to history to try to soothe investors' nerves CEO Christopher Boerner spoke of the "next chapter" for BMS at JP Morgan conference, said the company would be going through a "period of renewal." By Matthew Herper STAT+ | Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care The Coalition for Health AI counts Microsoft and Google as members and has the backing of federal health agencies, including theFDA. By Casey Ross STAT+ | Walgreens isn't acquiring anytime soon, per CEO Tim Wentworth of Walgreens says acquisitions are not needed to grow earnings long term and sees increased prescription volume as the key. By Brittany Trang Bebeto Matthews/AP Opinion: Americans are obsessed with health and fitness tracking. It's time for a data diet The answer to this problem isn't to get rid of health data altogether. But we do need to go on a data diet. By Samantha Kleinberg STAT+ | Boston Scientific acquires urology company Axonics for $3.7 billion Boston Scientific said it will buy Axonics, a device company tackling urinary and bowel disorders, for $3.7 billion. By Lizzy Lawrence STAT+ | The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma Ambrx develops antibody-drug conjugates, treatments that link powerful chemotherapies to homing devices meant to deliver them to tumors. By Andrew Joseph Courtesy Centerview Partners STAT+ | At JPM, biotech's most prolific dealmaker sees a rosy 2024 for acquisitions On the sidelines of the JP Morgan Healthcare Conference, dealmaker Eric Tokat of Centerview Partners provided his outlook for the coming year. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser